IOV-3001

· Iovance Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IOV-3001, covering 2025-12-03 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel [Phase 1, Phase 2]

See pricing